Compliance 360 – A podcast survival guide to US FDA enforcement and compliance
Join former FDA Investigations Branch Director Ricki Chase –now with Lachman Consultants – as she draws on her 16 years of agency experience to bring you the latest insights into FDA inspections, interactions and expectations. Compliance 360° is hosted by Medtech Insight PODCAST LINEUP November 28, 2018 Compliance 360° Part 14: Leverage FDA Data To […]
Indian pharma companies maintaining good compliance standards: Frances Zipp, CEO, Lachman Consultants
LCS’ CEO, Fran Zipp, was interviewed by Economic Times during a meeting of the ISPE India affiliate. Click here for the full interview.
Fran Zipp Elected Vice Chair of ISPE International Board of Directors
LCS would like to congratulate the newly elected International Board of Directors for ISPE for 2018-2019. This Board is responsible for devising strategy and governance of ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members by leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The […]
Visit Lachman Consultants at Booth 13/14 at AAM GRx + Biosims!
While you are attending the AAM GRx + Biosims meeting September 5-7, 2018 at the Hilton Baltimore, please be sure to visit Lachman Consultant Services at booth 13/14 and drop your business card for a chance to win an iPad 9.7 and Apple pen! As they say, you’ve got to be in it to win […]
Fran Zipp, CEO and President of LCS, to Moderate Panel at AAM GRx + Biosims Conference
On September 5, 2018, at 1:30 PM, Lachman Consultant Services’ CEO and President and CEO will be moderating a panel on Data Integrity at the AAM GRx + Biosims meeting. Ms. Zipp will be joined by Derek Glover (Head of Global Quality Systems and Compliance, Mylan Pharmaceuticals Inc.), Sarah Barkow, Ph.D. (Lead Consumer Safety Officer, […]
Keith Webber, Ph.D., new Vice President, Biotechnology at Lachman Consultant Services, Inc.
We are pleased to announce that Keith Webber, Ph.D. has accepted the position of Vice President, Biotechnology at Lachman Consultants, effective September 1, 2018. Dr. Webber delivers scientific direction, strategic guidance, and leadership regarding biotechnology products, new drugs, and generic drugs, based on his 30+ years of combined industry, U.S. FDA, and NIH experience. His […]
Lori-Ann Woodard, new Director, Medical Device at Lachman Consultant Services, Inc.
We are pleased to announce that Lori-Ann Woodard has accepted the position of Director, Medical Device at Lachman Consultants, effective August 20, 2018. Ms. Woodard delivers expertise in the implementation and management of Quality Management Systems for medical devices, Software as a Medical Device (SaMD), and combination products. She has more than 20 years of […]
Have You Heard the News? Lachman Opens its First European Office
We wanted you to be the first to know. We at Lachman are very excited to announce our recently opened first European office. The new office is located in the heart of beautiful Switzerland near Lake Lucerne (Luzern). This centrally-located European office gives us easier access to our clients in Europe, Asia, and the surrounding […]
Aloka Srinivasan, Ph.D., New Vice President, Regulatory Practice at Lachman Consultant Services, Inc.
We are pleased to announce that Aloka Srinivasan has accepted the position of Vice President, Regulatory Practice at Lachman Consultants, effective May 14, 2018. Dr. Srinivasan is a recognized professional with more than 15 years of experience serving at FDA and National Cancer Institute where she contributed to: establishing a DMF review division in FDA […]
